Renal Division, Department of Medicine, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China.
Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China.
Ren Fail. 2024 Dec;46(2):2364766. doi: 10.1080/0886022X.2024.2364766. Epub 2024 Jun 14.
AIMS: Recent accumulating evidence has recently documented a significant prevalence of right ventricular dysfunction (RVD) in end-stage renal disease (ESRD) patients. Tricuspid annular plane systolic excursion (TAPSE)/pulmonary-artery systolic pressure (PASP) ratio assessed with echocardiography might be a useful clinical index of right ventricular (RV) -pulmonary arterial (PA) coupling. The current study aimed to investigate the value of the TAPSE/PASP ratios in patients on maintenance hemodialysis (MHD). METHODS: We studied 83 times echocardiographic tests from 68 patients with MHD. The associations of TAPSE/PASP ratios with echocardiography variables, clinical characteristics, and biochemical parameters were analyzed, as well as the associations of TAPSE/PASP ratios with odds of all-cause mortality, cardiovascular disease (CVD) events and frequent intermittent dialysis hypotension (IDH). RESULTS: Correlation analysis showed TAPSE/PASP ratios positively correlated with LVEF and negatively correlated with E/A and E/e' values. For clinical and biochemical parameters, TAPSE/PASP ratios negatively correlated with BNP, NT-proBNP, age, CRP, and average interdialysis weight gain (ΔBW) and positively correlated with albumin. Logistic regression analysis, which induced the TAPSE/PASP ratio as a continuous variable (per 0.1 mm/mmHg increase), identified that the TAPSE/PASP ratio was associated with decreased CVD events (OR 0.386 [95% CI 0.231-0.645], < 0.001) and frequent IDH odds (OR 0.571 [95% CI 0.397-0.820], = 0.002). Moreover, the TAPSE/PASP ratio independently predicted CVD events (adjusted HR 0.539 [95% CI 0.391-0.743], < 0.001) during a follow-up period of 12 months. CONCLUSIONS: RVD, assessed by echocardiography TAPSE/PASP ratio, was found to be associated with increased risks of CVD events and frequent IDH in patients with MHD.
目的:最近越来越多的证据表明,终末期肾病(ESRD)患者右心室功能障碍(RVD)的发生率很高。超声心动图评估的三尖瓣环平面收缩期位移(TAPSE)/肺动脉收缩压(PASP)比值可能是右心室(RV)-肺动脉(PA)耦联的有用临床指标。本研究旨在探讨 TAPSE/PASP 比值在维持性血液透析(MHD)患者中的价值。
方法:我们研究了 68 例 MHD 患者的 83 次超声心动图检查。分析了 TAPSE/PASP 比值与超声心动图变量、临床特征和生化参数的相关性,以及 TAPSE/PASP 比值与全因死亡率、心血管疾病(CVD)事件和频繁间歇性透析低血压(IDH)的相关性。
结果:相关分析显示,TAPSE/PASP 比值与 LVEF 呈正相关,与 E/A 和 E/e' 值呈负相关。对于临床和生化参数,TAPSE/PASP 比值与 BNP、NT-proBNP、年龄、CRP 和平均透析间期体重增加(ΔBW)呈负相关,与白蛋白呈正相关。Logistic 回归分析将 TAPSE/PASP 比值作为连续变量(每增加 0.1mm/mmHg),结果表明 TAPSE/PASP 比值与降低 CVD 事件(OR 0.386 [95%CI 0.231-0.645], < 0.001)和频繁 IDH 几率(OR 0.571 [95%CI 0.397-0.820], = 0.002)相关。此外,TAPSE/PASP 比值独立预测 CVD 事件(校正 HR 0.539 [95%CI 0.391-0.743], < 0.001)在 12 个月的随访期间。
结论:超声心动图 TAPSE/PASP 比值评估的 RVD 与 MHD 患者 CVD 事件和频繁 IDH 风险增加相关。